SpeeDx
Sydney, AU · 2 known investors
Find your way into SpeeDx
314 people in our graph can introduce you to the SpeeDx team.
Sign up to see every warm intro you have to SpeeDx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the SpeeDx team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
SpeeDx develops PCR-based diagnostic tests for sexually transmitted infections that detect pathogens and antibiotic resistance markers, enabling clinicians to make informed treatment decisions. The tests are designed for use with standard laboratory equipment in clinical settings.
Founders & leadership


Investors · 2
How we know: Tenmile's portfolio page · funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
Funding
SEC filings, press & company announcements$26M disclosed across 1 of 4 rounds · 2019–2023
- $26MraisedFeb 2023 · 2 sourcesSource ↗
- Undisclosed amountSeries BFeb 2020Source ↗
- Undisclosed amountSeries AApr 2019Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does SpeeDx do?
- SpeeDx develops PCR-based diagnostic tests for sexually transmitted infections that detect pathogens and antibiotic resistance markers, enabling clinicians to make informed treatment decisions. The tests are designed for use with standard laboratory equipment in clinical settings.
- Who founded SpeeDx?
- SpeeDx was founded by Alison Todd, Elisa Mokany.
- Who are SpeeDx's investors?
- SpeeDx's investors include Tenmile, Northpond Ventures.
- How much funding has SpeeDx raised?
- SpeeDx has disclosed $26M raised across 1 of its 4 known rounds.
- Where is SpeeDx headquartered?
- SpeeDx is headquartered in Sydney, AU.

